breast cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who received neoadjuvant chemotherapy for HER2 receptor-positive or estrogen receptor-negative stage 1 to 3 breast cancer between April 1, 2012 and December 31, 2020 and achieved clinical response.
Exclusion criteria
Exclusion criteria: * Patients who did not undergo curative surgery after neoadjuvant chemotherapy * Patients with postoperative recurrence (regardless of site) * Patients diagnosed with hereditary breast cancer-ovarian cancer syndrome
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient Intentions Regarding the Impact of the Introduction of Abbreviated Breast Surgery on Local Recurrence Rates and Survival | — |
Countries
Japan
Contacts
Mie University Hospital Breast Surgery